PTCH1 and nevoid basal cell carcinoma syndrome: It was not until 1996, when two independent research groups discovered somatic inactivating PTCH1 gene mutations in a genetic skin cancer disease, Gorlin syndrome, and subsequent discovery of activating mutations of smoothened (SMO) in skin cancer basal cell carcinomas [1,2,3].